AstraZeneca’s trial of Imfinzi reports significant overall survival benefit
Lung cancer is a leading cause of cancer death among both men and women. Credit: Nephron.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more